Deferasirox
- Product NDC
- 0480-7013
- 11-digit product format
- 004807013
- Labeler code
- 0480
- Product ID
- 0480-7013_41368299-3cb6-4cee-885e-5c1cc8e4fee6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals, Inc.
- Application
- ANDA207124
- Marketing category
- ANDA
- Marketing start
- 2024-11-01
- Substance
- DEFERASIROX
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207124-001 | DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | |
| A207124-002 | DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | |
| A207124-003 | DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207124-001 | AB |
| A207124-002 | AB |
| A207124-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2022-09-23 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | 2022-09-23 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | 2022-09-23 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | 2022-09-23 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | 2022-09-23 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207124-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | 2022-09-23 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207124-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | 2022-09-23 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207124-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | 2022-09-23 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207124-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207124-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207124-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207124-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207124-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207124-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207124-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207124-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207124-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207124-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207124-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207124-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207124-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207124-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207124-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207124-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207124-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207124-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207124-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207124-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207124-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207124-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207124-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207124-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207124-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207124-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207124-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207124-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207124-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207124-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207124-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207124-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207124-003 | AB | 1 | 79d66fd596c7… |
| 2023-01-26 05:58 UTC | 2023-01 | A207124-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A207124-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A207124-003 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207124-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207124-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207124-003 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207124-001 | AB | 1 | f41ea6bd6efb… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Deferasirox
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEFERASIROX | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V8G4MOF2V9 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e9054806-2721-4736-9aef-81ffb8db75d1 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e1ec29c-8ce7-9963-3c87-cf7d9cd3b139 | Product name | 5 | 20250624 |
| 0feb0248-301d-406d-9b41-7d80ddbec8a8 | Product name | 4 | 20201216 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0480-7013-56 | Deferasirox | 30 in 1 BOTTLE | TABLET, FOR SUSPENSION | 30 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0480-7013-56 | EA - Each | 0480-7013 | 514a9cb6-3627-4c68-94b5-77e20783d42d | 1 | 2024-12-10 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Deferasirox | DEFERASIROX | Teva Pharmaceuticals, Inc. | e9054806-2721-4736-9aef-81ffb8db75d1 | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | 207124 ANDA207124 0480-7013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 597768 | deferasirox 125 MG Tablet for Oral Suspension | PSN | e9054806-2721-4736-9aef-81ffb8db75d1 | 7 |
| 597770 | deferasirox 250 MG Tablet for Oral Suspension | PSN | e9054806-2721-4736-9aef-81ffb8db75d1 | 7 |
| 597772 | deferasirox 500 MG Tablet for Oral Suspension | PSN | e9054806-2721-4736-9aef-81ffb8db75d1 | 7 |
| 597768 | deferasirox 125 MG Tablet for Oral Suspension | SCD | e9054806-2721-4736-9aef-81ffb8db75d1 | 7 |
| 597770 | deferasirox 250 MG Tablet for Oral Suspension | SCD | e9054806-2721-4736-9aef-81ffb8db75d1 | 7 |
| 597772 | deferasirox 500 MG Tablet for Oral Suspension | SCD | e9054806-2721-4736-9aef-81ffb8db75d1 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 0480-7013-56 | 00480701356 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0480-7013-56) | 2024-11-01 | No | No | Current |